|
[1]
|
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial
Genome Medicine,
2024
DOI:10.1186/s13073-024-01297-5
|
|
|
|
|
[2]
|
A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma
Cancer Reports,
2022
DOI:10.1002/cnr2.1616
|
|
|
|
|
[3]
|
Data and knowledge management in translational research: implementation of the eTRIKS platform for the IMI OncoTrack consortium
BMC Bioinformatics,
2019
DOI:10.1186/s12859-019-2748-y
|
|
|
|
|
[4]
|
Novel Therapies for Relapsed and Refractory Neuroblastoma
Children,
2018
DOI:10.3390/children5110148
|
|
|
|
|
[5]
|
Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
PLOS ONE,
2018
DOI:10.1371/journal.pone.0208924
|
|
|
|
|
[6]
|
Overview and recent advances in the treatment of neuroblastoma
Expert Review of Anticancer Therapy,
2017
DOI:10.1080/14737140.2017.1285230
|
|
|
|
|
[7]
|
Integration and Visualization of Translational Medicine Data for Better Understanding of Human Diseases
Big Data,
2016
DOI:10.1089/big.2015.0057
|
|
|
|
|
[8]
|
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
Cancer Medicine,
2015
DOI:10.1002/cam4.436
|
|
|
|
|
[9]
|
Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
Cancer Medicine,
2015
DOI:10.1002/cam4.436
|
|
|
|
|
[10]
|
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance
Pediatric Blood & Cancer,
2014
DOI:10.1002/pbc.25039
|
|
|
|
|
[11]
|
Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials
PLoS ONE,
2014
DOI:10.1371/journal.pone.0090028
|
|
|
|
|
[12]
|
A multi-site feasibility study for personalized medicine in canines with Osteosarcoma
Journal of Translational Medicine,
2013
DOI:10.1186/1479-5876-11-158
|
|
|
|
|
[13]
|
Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors
Journal of Translational Medicine,
2013
DOI:10.1186/1479-5876-11-213
|
|
|
|